标题

Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof

授权日

2015-02-10

公开（公告）号

US8951742

申请日

2009-02-02

公开（公告）日

2015-02-10

当前申请（专利权）人

MEDIZINISCHE HOCHSCHULE HANNOVER

发明人

WOLLERT, KAI C. | KEMPF, TIBOR | WALLENTIN, LARS | DREXLER, HELMUT

简单同族

AT511656T | AU2007280413A1 | AU2007280413B2 | BRPI0715126A2 | BRPI0715126B1 | CA2660691A1 | CA2660691C | CN106018820A | CN106018820B | EP2047275A2 | EP2047275B1 | EP2315034A2 | EP2315034A3 | HK1136627A1 | HK1229887A | HK1229887A1 | JP2009545735A | JP5309026B2 | KR101245877B1 | KR1020090047451A | MX2009000914A | SG149375A1 | US20110065204A1 | US20150362511A1 | US20200081020A1 | US8951742 | WO2008015254A2 | WO2008015254A3

简单同族成员数量

28

简单同族被引用专利总数

90

诉讼案件数

0

法律状态/事件

授权 | 权利转移